Loading company financials…
NEW YORK STOCK EXCHANGE, INC. · Consumer products · CIK 0000021665
$97.39
+4.27% · live
Updated
$78.03B market value
From COLGATE PALMOLIVE CO's FY2025 10-K, filed Feb 23, 2026 · read the filing
COLGATE PALMOLIVE makes soap, cleaning and personal care products. It took in $20.38B last year, which makes it a large company. Of every dollar it sells, about 10 cents is left as profit.
The financial picture is led by profitability, debt and accounting, with growth worth watching.
A conclusion from the filings, not a recommendation. Detailed figures and supporting evidence appear in their dedicated sections below.
Financial health
Strong finances across the board.
From COLGATE PALMOLIVE CO's FY2025 annual filing · share price scored separately
Largest year-over-year changes in FY2025
Operating income
$4.27B → $3.31B
Profit
$2.89B → $2.13B
Operating margin
21.2% → 16.2%
Profit margin
14.4% → 10.5%
Measured against FY2024, from the 10-K filed Feb 23, 2026
Deteriorated: -22.5%
$4.27B to $3.31BSignificant
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Deteriorated: -26.2%
$2.89B to $2.13BSignificant
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
How the latest move compares (quote live), and what was published around it
CL rose 4.27% on the latest quote. The average Consumer Staples company tracked here moved +4.04%, and the S&P 500 −1.04%. That is in line with its sector and 5.3 points above the market.
Expectations
Not from the filings — what other people are betting on, and what the price already assumes.
The growth rate someone buying today is paying for, against what the company has delivered
At today's price, the market is paying for free cash flow to grow by about 8% a year for the next 10 years. Over the last 10 years it grew by about 5% a year.
The essentials
Each answered from the filings, with the numbers behind it.
Yes. It keeps about 10 cents of every dollar of sales as profit, earning $2.13B last year.
Barely. Sales were roughly flat, up 1.4%.
No. At its current cash flow it could clear its debt in about 1.6 years. For every $1 it owes, it owns $1.02 in assets.
Core operating and valuation reference metrics
Income
This company pays no dividend. It keeps its profits and reinvests them in the business instead, so any return would have to come from the share price.
Figures from the FY2025 annual filing
Last year it earned $2.13B and generated $4.20B of cash from operations.
Reported annual figures
As reported to the SEC, in USD. Hover or show sources to see where each figure came from.
| Income statement | FY202510-K · Feb 23, 2026Filing for FY2025 | FY202410-K · Feb 13, 2025Filing for FY2024 | FY202310-K · Feb 15, 2024Filing for FY2023 | FY202210-K · Feb 16, 2023Filing for FY2022 | FY202110-K · Feb 16, 2023Filing for FY2021 | ChangeFY2025 vs FY2024 |
|---|---|---|---|---|---|---|
| RevenueWhat is this? | $20.38B | $20.10B | $19.46B | $17.97B | $17.42B | +1.4% |
| Cost of revenue | $8.13B | $7.94B | $8.13B | $7.72B | $7.05B | +2.4% |
| Gross profit | $12.25B | $12.16B | $11.33B | $10.25B | $10.38B | +0.7% |
| Gross marginGross profit ÷ revenueWhat is this? | 60.1% | 60.5% | 58.2% | 57.0% | 59.6% | −0.4 pts |
| Selling, general and administrative | $7.90B | $7.73B | $7.15B | $6.57B | $6.41B | +2.3% |
| Operating income | $3.31B | $4.27B | $3.98B | $2.89B | $3.33B | −22.5% |
| Operating marginOperating income ÷ revenueWhat is this? | 16.2% | 21.2% | 20.5% | 16.1% | 19.1% | −5.0 pts |
| Interest expense | $267.0M | $292.0M | $299.0M | $172.0M | $120.0M | −8.6% |
| Income before tax | $3.06B | $3.96B | $3.39B | $2.66B | $3.09B | −22.7% |
| Net income | $2.13B | $2.89B | $2.30B | $1.78B | $2.17B | −26.2% |
| Net marginNet income ÷ revenueWhat is this? | 10.5% | 14.4% | 11.8% | 9.9% | 12.4% | −3.9 pts |
| Earnings per shareNet income ÷ shares outstanding at the period end — close to, but not the same as, the reported EPSWhat is this? | $2.66 | $3.56 | $2.80 | $2.15 | $2.58 | −25.2% |
† calculated from other reported figures, such as total liabilities as assets minus equity.
This company's latest filing beside its peers' stored scores
| Company | Health | F-Score | Revenue growth | Profit margin | P/E | Debt to equity |
|---|---|---|---|---|---|---|
| CLCOLGATE PALMOLIVE CO · this page | 9.0/10 | 5/9 |
Insider activity, ownership stakes and what's coming — straight from EDGAR, before any article is written about it
Officers, directors and major shareholders must report within two business days of a trade.
Was granted or awarded shares — 271 shares at $87.42 ($23.7K)
Holds 40,725 shares after this filing.
Was granted or awarded shares — 214 shares at $87.42 ($18.7K)
Holds 8,058 shares after this filing.
20 recent filings, newest first. Each is labelled from its form and item numbers, not from its wording.
Quarterly report for Q2 FY2026
Operating margin −2.2 pts · Gross profit +7.4% · Operating income -5.9% — against Q2 FY2025
Read the filingPublished results
Read the filingWrite down why you are following COLGATE PALMOLIVE CO, what has to go right and what would change your mind, then see each new annual report measured against it. Sign in to start one.
Go deeper
Every figure above traces back to a filing in the timeline, each linked to the document itself.
The 235 subsidiaries named in its 10-K, incorporated across 85 places. A filer lists the significant ones and may leave the rest out, so this is the floor rather than the full count.
Every company's figures are checked for internal consistency: the balance sheet adding up, figures sharing one currency, cash flow and share counts within plausible ranges, and how recent the latest annual report is. Nothing here changes a figure.
Financial figures are from CL's 10-K for fiscal year 2025 (period ending 2025-12-31, filed Feb 23, 2026), reported under the US GAAP taxonomy. View the source filing.
4 of 4 scored areas had enough reported figures to judge
The score averages profitability, growth, debt and accounting. All four had enough reported figures. Cash generation is shown for context and already feeds profitability. Valuation is scored separately, because a share price says nothing about whether the business is sound. 9 of the 9 Piotroski checks could be evaluated. How the score works
Each year scored only from its annual report as it was first filed
| Fiscal year | Health | F-Score | Scored from |
|---|---|---|---|
| FY2025 | 9.0 | 5/9 | 10-K, filed Feb 23, 2026 |
| FY2024 | 9.0 | 8/9 | 10-K, filed Feb 13, 2025 |
| FY2023 | 9.0 | 8/9 | 10-K, filed Feb 15, 2024 |
| FY2022 | 7.0 | 5/9 | 10-K, filed Feb 16, 2023 |
| FY2021 | 9.0 | 6/9 | 10-K, filed Feb 17, 2022 |
| FY2020 | 9.0 | 7/9 | 10-K, filed Feb 18, 2021 |
A later restatement never reaches back into an earlier year, and every year is scored without a share price, so the latest point can differ a little from the headline score, which uses today's price.
Every check behind the three models, and what each one tests
5 of 9 checks passed
Nine yes-or-no tests of whether this year's finances improved on last year's.
7.04
In the safe zone
For this model, above 2.99 is safe and below 1.81 is distress.
Distance from bankruptcy, from a model fitted on companies that did and did not go bust. It describes a balance sheet's shape today; it does not forecast a failure.
-3.02
Below the threshold — nothing unusual flagged
Scores above -1.78 are the ones the model associates with earnings manipulation.
Screens eight accounting ratios for the pattern earnings manipulators tend to leave. A flag is a reason to read the filing closely, never evidence of wrongdoing.
Every figure above comes from the FY2025 filing as filed with the SEC.
Deteriorated: −5.0 pts
21.2% to 16.2%Significant
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Deteriorated: −3.9 pts
14.4% to 10.5%Significant
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Deteriorated: -25.2%
$3.56 to $2.66Significant
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: +17.5%
$1.10B to $1.29BSignificant
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Improved: -5.7%
$7.29B to $6.87BNotable
Why it matters: Rising debt is not automatically bad — borrowing to build something that earns more than the interest is ordinary. It matters when it grows faster than the profit meant to service it.
Improved: -1.4%
812.6M to 801.2MNotable
Why it matters: The company bought back stock, so each remaining holding owns slightly more of it. Worth checking it was not funded by borrowing.
Q2 FY2026 against Q2 FY2025, from the 10-Q filed Jul 31, 2026 — read it.
Improved: +7.4%
$3.07B to $3.30BNotable
Why it matters: What is left of sales after the direct cost of producing them. It normally moves with revenue, so a move out of step with revenue is the part worth noticing.
Deteriorated: -5.9%
$1.08B to $1.02BNotable
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Deteriorated: -6.7%
$743.0M to $693.0MNotable
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: +1.4 pts
60.1% to 61.5%Notable
Why it matters: What survives each sale before overheads. Falling gross margin usually means the company is discounting or its input costs rose — it is the earliest place pricing pressure shows.
Deteriorated: −2.2 pts
21.1% to 19.0%Notable
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Deteriorated: −1.6 pts
14.5% to 12.9%Notable
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Deteriorated: -5.4%
$0.92 to $0.87Notable
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Deteriorated: +9.5%
$7.14B to $7.82BNotable
Why it matters: Rising debt is not automatically bad — borrowing to build something that earns more than the interest is ordinary. It matters when it grows faster than the profit meant to service it.
Improved: +12.8%
$1.22B to $1.37BNotable
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Improved: -1.4%
808.2M to 797.2MNotable
Why it matters: The company bought back stock, so each remaining holding owns slightly more of it. Worth checking it was not funded by borrowing.
Q2 FY2026 against Q1 FY2026, from the 10-Q filed Jul 31, 2026 — read it. Quarter-to-quarter moves include seasonal swings — a retailer's holiday quarter — which the year-earlier comparison removes.
Improved: +5.4%
$964.0M to $1.02BNotable
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Improved: +7.3%
$646.0M to $693.0MNotable
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: +7.7%
$0.81 to $0.87Notable
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
5 other measures barely moved. Figures compare the two most recent annual filings — read the latest one. Moves are graded on fixed lines — 5%, 15% and 40% for amounts, and 1, 3 and 8 points for margins — as notable, significant or critical. Nothing here reads the management commentary, which is where a company explains its own numbers.
These coincide with the move in time. None is presented as its cause: a price can move on news that names no company, on the wider market, or on trading that no document records.
Filter by minute, hour, day or week — or compare against peers
Loading price history…
Discounted at 8%–10% a year, with growth settling to 2.5% after 10 years. Those rates are ordinary choices, not measurements: across that range the assumed growth works out between 5% and 10%. This describes what the price implies — it is not a forecast, and not a view on whether the price is right.
Opinions from 30 analysts covering this company, as of . Their views, not this site's.
Of 30 analysts publishing on this company, 5 say strong buy, 15 say buy and 10 say hold. Analysts are paid to publish a view and are wrong often; the split above says how much they agree with each other, which is the part a single headline rating hides.
Published by Finnhub. Analyst coverage skews towards larger companies and towards optimism — sell ratings are rare across the whole market, so a company with none is ordinary rather than endorsed.
Measured on and published about a week later — this is a fortnightly snapshot, not a live position.
About 3.0% of this company's shares have been borrowed and sold by people expecting to buy them back cheaper. That is a bet the price falls. Those people can be wrong, and when a heavily shorted share rises they have to buy it back, which pushes it up further.
Collected by FINRA from broker-dealers twice a month. It counts positions, not intentions, and some of it is hedging rather than a directional bet against the company.
Nothing in this section is a figure this company reported about itself. These are expectations and positions — what the price implies, what analysts have published, what short sellers are betting, and what large funds held at the last count. WylthIQ reports them; it does not endorse them, does not forecast prices, and takes no view on whether any of them will turn out to be right.
The trailing P/E is 27.7x — investors pay $27.7 for each $1 of trailing profit.
Nothing unusual. Its accounting patterns look like those of companies that report earnings straightforwardly.
| 1.4% |
| 10.5% |
| 36.60x |
| 295.65x |
| PGPROCTER & GAMBLE Co | 9.0/10 | 7/9 | 3.3% | 18.4% | 23.99x | 1.33x |
|---|
| KMBKIMBERLY CLARK CORP | 7.3/10 | 5/9 | -2.1% | 12.3% | 18.45x | 10.38x |
|---|
| CHDCHURCH & DWIGHT CO INC /DE/ | 9.0/10 | 7/9 | 1.6% | 11.9% | 36.34x | 1.23x |
|---|
| CLXCLOROX CO /DE/ | 9.0/10 | 7/9 | 0.2% | 11.4% | 13.43x | 15.82x |
|---|
| Median of peers | 9.0/10 | — | 0.9% | 12.1% | 21.22x | 5.86x |
|---|
Peers come from the company's industry classification. A difference describes the companies; it does not rank them.
Was granted or awarded shares — 300 shares at $87.42 ($26.2K)
Holds 43,310 shares after this filing.
Was granted or awarded shares — 3,908 shares
Holds 27,021 shares after this filing.
Was granted or awarded shares — 8,045 shares
Holds 79,029 shares after this filing.
Was granted or awarded shares — 4,597 shares
Holds 11,447 shares after this filing.
Was granted or awarded shares — 7,355 shares
Holds 79,503 shares after this filing.
Was granted or awarded shares — 29,649 shares
Holds 379,700 shares after this filing.
Notice filed ahead of a planned sale — the sale itself has not necessarily happened yet.
Filed notice to sell 10,000 shares ($920.5K) on or after .
Shares originally obtained via Vesting of restricted stock unit awards.
Filed notice to sell 4,170 shares ($389.4K) on or after .
Shares originally obtained via Exercise of employee stock options.
Filed notice to sell 161,021 shares ($14.9M) on or after .
Shares originally obtained via Exercise of employee stock options.
Filed notice to sell 1,762 shares ($159.6K) on or after .
Shares originally obtained via Exercise of employee stock options.
Filed notice to sell 161,021 shares ($14.8M) on or after .
Shares originally obtained via Exercise of employee stock options.
Estimated from how often this has happened before, not a confirmed date.
Not investment advice, and not a signal to act on by itself — a filing says what happened, not why, and insiders trade for ordinary reasons having nothing to do with where they think the company is headed.
Held a shareholder vote
Quarterly report for Q1 FY2026
Revenue +8.4% · Operating margin −3.8 pts · Free cash flow +27.9% — against Q1 FY2025
Read the filingAnnounced restructuring or exit costs · Published results
Read the filingHad a director or senior officer leave or join
Read the filingProxy statement for a shareholder meeting
Read the filingReported another event
Read the filingHad a director or senior officer leave or join
Read the filingAnnual report for FY2025
Operating margin −5.0 pts · Operating income -22.5% · Profit -26.2% — against FY2024
Read the filingPublished results
Read the filingReported another event
Read the filingQuarterly report for Q3 FY2025
Gross margin −1.7 pts · Long-term debt -7.6% · Shares in issue -1.3% — against Q3 FY2024
Read the filingAnnounced restructuring or exit costs · Published results
Read the filingQuarterly report for Q2 FY2025
Long-term debt -12.3% · Cash +9.5% · Shares in issue -1.1% — against Q2 FY2024
Read the filingAnnounced restructuring or exit costs · Published results
Read the filingHad a director or senior officer leave or join
Read the filingHeld a shareholder vote
Read the filingReported another event
Read the filingQuarterly report for Q1 FY2025
Operating margin +1.2 pts · Long-term debt -19.4% · Free cash flow -14.2% — against Q1 FY2024
Read the filingThe first 40 of 235. The rest are in the exhibit.
Source: Exhibit 21 of the 10-K filed 2026-02-23. These are legal entities, not brands or acquisitions — a company that bought a business may hold it inside an entity named here, or inside one small enough that the rule does not require naming it at all.
Coverage from the last 30 days
Canadian dollar strengthens as oil prices, BoC rate hike bets support loonie
Yahoo ·
Will Colgate-Palmolive (CL) Beat Estimates Again in Its Next Earnings Report?
Yahoo ·
FTSE 100 today: Stocks fall as Gulf war lifts oil, miners slide on weaker metals
Yahoo ·
U.S. stock futures fall as investors weigh Tesla, Meta earnings
Yahoo ·
Unconfirmed Qatar-Pakistan Iran peace proposal lifts stocks, weighs on oil
Yahoo ·
Global equities: Rally or selloff? Which catalysts matter most?
Yahoo ·
Clorox vs. Colgate: One Pays Nearly 6%, but Is It a Dividend Trap?
Yahoo ·
Oil holds near five-month high as Hormuz attacks threaten supply recovery
Yahoo ·
5 Dividend Stocks for Investors Who Want Income Without the Market’s Wild Swings
Yahoo ·
$11,033 in Annual Dividends: What You Keep in a Roth IRA vs. a Taxable Account
Yahoo ·
JP Morgan Maintains Overweight on Colgate-Palmolive, Raises Price Target to $104
Benzinga ·
Procter & Gamble's Innovation Push: Catalyst for Long-Term Growth?
Yahoo ·
Primary sources and further research